During the past decade, OnkoZentrum Luzern at Klinik St. Anna conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "OnkoZentrum Luzern at Klinik St. Anna" are "Colorectal Cancer" (2 trials). Many other conditions were trialed in "OnkoZentrum Luzern at Klinik St. Anna" in a lesser frequency.

Most popular intervention types in "OnkoZentrum Luzern at Klinik St. Anna" are "Drug" (2 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "panitumumab" (1 trials), "radiation therapy" (1 trials) and "sorafenib tosylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "OnkoZentrum Luzern at Klinik St. Anna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "OnkoZentrum Luzern at Klinik St. Anna". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in OnkoZentrum Luzern at Klinik St. Anna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in OnkoZentrum Luzern at Klinik St. Anna, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".